Kriti Nutrients share price & results
- Jun 2026
- Sept 2026
Indore (MP)-based soybean processor making branded 'Kriti' edible oils (soybean, sunflower, mustard, groundnut) and value-added soy protein/feed products.
Reported
The figures, each with its period
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 247 | +7.9% YoY | Quarterly, as filed | Quarter to Jun 2026 | Revenue from operations as filed. |
| Operating margin | 4.8 | −0.2 pts YoY | Operating profit / revenue | Quarter to Jun 2026 | For the quarter; a change is in percentage points. |
| Net profit | 9.1 | −1.6% YoY | Quarterly, as filed | Quarter to Jun 2026 | Profit after tax as filed. |
| Return on equity | 15.12 | −3.2 pts | Trailing twelve months | TTM to Jun 2026 | Adjusted profit attributable to owners ÷ average owners’ equity. |
| Free cash flow margin | 6.33 | +2.6 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | 21.14 | +18.3 pts | Trailing twelve months | TTM to Jun 2026 | Revenue change against the same period one year earlier. |
Price
Performance −27.3% 1Y
1Y: ₹87 on 24 Oct 2025 → ₹63.29. High ₹99.97 (27 Apr 2026), low ₹53.87 (30 Mar 2026).
- Previous close
- ₹65.48
- Market cap
- ₹343 Cr
- 52-week range
- ₹53.87 – ₹99.97
- One year
- −27.86%
- Price to earnings (TTM to Jun 2026)
- 10.29×
- Return on equity (TTM to Jun 2026)
- 15.12%
Overview
- Symbol
- NSE:KRITINUT
- Exchange
- NSE
- Currency
- INR
What Kriti Nutrients Limited does
Based on the company's own presentations, annual report and earnings calls.
Kriti Nutrients processes soybean at an integrated facility in Dewas, Madhya Pradesh that houses solvent extraction, vegetable-oil refining, lecithin production, effluent treatment and a packaging/moulding unit. It sells a portfolio of refined cooking oils under the 'Kriti' brand through a dealer and distributor network concentrated in Madhya Pradesh and Rajasthan, and separately manufactures value-added, protein-based soy derivatives supplied to the food, pharmaceutical, dairy, aquaculture and poultry industries. Products are also exported to overseas markets.
Segments
- Edible oil business
- Protein-based feed and foods business
- Manufacturing facility
- 1 integrated plant (Dewas, Madhya Pradesh) with solvent extraction, oil refining, lecithin production, effluent treatment and packaging/moulding units
- Retail outlet coverage
- 16,500 outlets across 46 districts of Madhya Pradesh and 6 districts of Rajasthan (FY25)
- Distribution team
- 60 distributor salespersons + 43 company sales officers
- Consumer pack volume
- 9,940 MT in FY25 (up from 7,395 MT in FY24)
- Export reach
- 22 countries (edible oil exports); protein-based products exported to 30+ countries
- Dealer relationship tenure
- ~26% of dealer partners associated for 15+ years
Fundamentals
Ratios, each with its period
Current values with the period they cover; the trend reads across the 3 fiscal years held (Mar 2024 to Mar 2026).
Financials
What the filings say
Net profit, year on year: −2% (quarter to jun 2026 against jun 2025).
| Line item | Sept 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
|---|---|---|---|---|---|---|---|---|
| Sales | 174 | 173 | 200 | 229 | 213 | 224 | 255 | 247 |
| Expenses | 161 | 162 | 194 | 218 | 202 | 213 | 246 | 235 |
| Operating profit | 12 | 11 | 6 | 11 | 11 | 12 | 9 | 12 |
| Operating margin | 7.1% | 6.4% | 3.0% | 5.0% | 5.3% | 5.1% | 3.6% | 4.8% |
| Other income | 2 | 2 | 2 | 2 | 2 | 2 | 2 | 2 |
| Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 2 |
| Profit before tax | 13 | 12 | 6 | 12 | 12 | 12 | 9 | 12 |
| Tax rate | 23.8% | 31.4% | 23.1% | 22.4% | 23.8% | 22.3% | 33.3% | 22.8% |
| Net profit | 10 | 8 | 5 | 9 | 9 | 9 | 6 | 9 |
| EPS (₹ per share) | 1.91 | 1.65 | 0.99 | 1.84 | 1.84 | 1.84 | 1.24 | 1.81 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 797 | 684 | 734 | 922 |
| Expenses | 766 | 622 | 686 | 878 |
| Operating profit | 31 | 62 | 48 | 43 |
| Other income | 4 | 4 | 8 | 8 |
| Interest | 4 | 1 | 1 | 1 |
| Depreciation | 4 | 5 | 5 | 6 |
| Profit before tax | 28 | 61 | 50 | 45 |
| Net profit | 21 | 45 | 37 | 34 |
| Line item | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Equity capital | 5 | 5 | 5 | 5 | 5 | 5 |
| Reserves | 107 | 127 | 171 | 207 | 224 | 224 |
| Borrowings | 38 | 40 | 12 | 3 | 6 | 9 |
| Other liabilities | 18 | 20 | 20 | 23 | 21 | 34 |
| Total liabilities | 168 | 193 | 209 | 238 | 256 | 273 |
| Fixed assets | 47 | 49 | 58 | 58 | 56 | 57 |
| Capital work in progress | 5 | 6 | 1 | 0 | 2 | 1 |
| Investments | 0 | 0 | 12 | 45 | 52 | 55 |
| Other assets | 115 | 138 | 139 | 135 | 147 | 161 |
| Total assets | 168 | 193 | 209 | 238 | 256 | 273 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Cash from operations | 9 | -11 | 20 | 50 | 32 | 64 |
| Cash from investing | 1 | -20 | -3 | -29 | -29 | -9 |
| Cash from financing | -7 | 31 | -1 | -30 | -11 | -10 |
| Net cash flow | 3 | 1 | 15 | -10 | -8 | 45 |
| Free cash flow | 4 | -19 | 13 | 41 | 27 | 59 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| Debtor days | 5 | 6 | 6 | 11 | 4 | 5 |
| Inventory days | 22 | 28 | 33 | 30 | 22 | 22 |
| Days payable | 4 | 4 | 3 | 3 | 3 | 6 |
| Cash conversion cycle | 22 | 30 | 35 | 38 | 24 | 20 |
| Working capital days | 23 | 24 | 24 | 29 | 24 | 15 |
| Return on capital employed | 21.0% | 15.0% | 20.0% | 34.0% | 24.0% | 20.0% |
| Dividend payout | 6.0% | 7.0% | 6.0% | 3.0% | 4.0% | 49.0% |
What the price assumes
AttractiveTo justify its price of ₹63, this stock must grow earnings at 0% every year for 7 years. Our analysis caps realistic growth at ~18%. At that growth it is worth ₹161 — upside of 154%.
- Growth the price implies
- 0.2% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 17.6% a year
- net profit, FY23–FY26 · EPS 17.7%
- The gap
- -0.2 pp
- 154% downside if it only repeats history
Ownership
Who owns it
Promoters hold 66.69% as of Sept 2026; institutions added 0.00 pts since Jun 2026.
- Promoters 66.69%
- Foreign institutions 0.00%
- Domestic institutions 0.03%
- Public 33.29%
Who is on the register
Named in the Sep 2026 filing
Every holder of Kriti Nutrients Limited above SEBI's 1% disclosure line, and what changed since Jun 2026.
| Holder | Stake | Change |
|---|---|---|
| 61.72% | unchanged | |
| 5.05% | unchanged | |
| 4.07% | unchanged | |
| 2.72% | unchanged | |
| 1.56% | unchanged | |
| 1.42% | unchanged | |
| 1.40% | unchanged | |
| 1.20% | unchanged | |
| 1.08% | unchanged | |
| 0.76% | unchanged | |
| 0.08% | unchanged | |
| 0.06% | unchanged |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Your own record
Start an Inve Case for Kriti Nutrients Limited
Free account: one company. Everything above stays public.
Write why you follow Kriti Nutrients Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Fast Moving Consumer Goods companies
Learn to analyse Kriti Nutrients Limited
Guides on how to read this kind of business and the numbers that matter.